SCHEMBL5147069

SCHEMBL5147069

COc1cc(C(N)=O)ccc1-n1c2c(c3ccccc31)C(=O)CCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 2/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
TP53 P04637 1/20 0.40
CREBBP Q92793 1/20 0.40
LMNA P02545 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPK1 P28482 1/20 0.38
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145477 0.86 HDAC1 (0.46) HDAC1HDAC6ALDH1A1TP53CREBBP
SCHEMBL5147126 0.84 HDAC1 (0.46) HDAC1HDAC6MAPTTP53CREBBP
SCHEMBL5147078 0.84 HDAC1 (0.48) HDAC1HDAC6MAPTTP53CREBBP
SCHEMBL5147102 0.84 HDAC1 (0.48) HDAC1HDAC6ALDH1A1TP53CREBBP
SCHEMBL5147172 0.81 HDAC1 (0.44) HDAC1HDAC6TP53CREBBPPTGS1
SCHEMBL5147109 0.80 GAA (0.51) HDAC1HDAC6MAPTALDH1A1HTT
SCHEMBL5147074 0.79 PTGS2 (0.48) HDAC1HDAC6ALDH1A1HTTPTGS1
SCHEMBL5147042 0.79 HDAC1 (0.44) HDAC1HDAC6TP53CREBBPPTGS1
SCHEMBL14422435 0.78 HDAC1 (0.43) HDAC1HDAC6MAPTALDH1A1NPSR1
SCHEMBL5147159 0.76 HDAC1 (0.45) HDAC1HDAC6MAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885MAPT 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.